Isatuximab Plus Carfilzomib and Dexamethasone Vs. Carfilzomib and Dexamethasone in Relapsed/refractory Multiple Myeloma (ikema): Interim Analysis of a Phase 3, Randomized, Open-Label Study
Hematology, Transfusion and Cell Therapy(2020)
关键词
International Myeloma Working Group
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要